Picture of WuXi Biologics (Cayman) logo

2269 — WuXi Biologics (Cayman) News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareHighly SpeculativeLarge CapHigh Flyer

Brief: Wuxi Biologics (Cayman) Says Revenue Expected To Increase 16%, Profit Up 54% For HY

July 24 (Reuters) - WuXi Biologics (Cayman) Inc 2269.HK:

REVENUE EXPECTED TO INCREASE 16%, PROFIT UP 54% FOR HY

INCREASE DUE TO STRATEGIES AND TECHNOLOGY PLATFORMS IN HY

Further company coverage: 2269.HK

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on WuXi Biologics (Cayman)

See all news